The Good, the Bad and the Living Dead: Venture Capital Cases in the Healthcare Industry
- ISBN-10
- 0976388804
- ISBN-13
- 9780976388807
- Category
- Biotechnology industries
- Pages
- 470
- Language
- English
- Published
- 2005-07
- Publisher
- Moment LLC
- Author
- Albert J. Henry
Description
A guide for people who aspire to practice as venture capitalists and also for those interested in gaining in-depth knowledge of the rigid system of venture capital. It explores the various aspects of venture capital investing. Almost 25% of venture capital companies are successful, while one third of them go bankrupt. Around 40% of these companies face difficulties coping with the growing economy. the companies in these different categories are respectively termed the good, the bad and the living dead.
Get the book
Similar books
-
Antibody Therapeutics: Product Development, Market Trends, and Strategic Issues
By John Morrow, Rathin DasAntibody Therapeutics: Product Development, Market Trends, and Strategic Issues
-
Theranos, Inc: Managing Risk in a High-flying Biotech Start-up
By James S. O'Rourke, Caitlin Kelley, Shareen LeeThe case describes how a start-up bio-tech company covered up failed quality control standards leading to an expose in the Wall Street Journal.
-
The International biotechnology directory 1989: products, companies, research and organizations
By Y. R. Alston, J. CoombsThe International biotechnology directory 1989: products, companies, research and organizations
-
Antibody Therapeutics: Production, Clinical Trials, and Strategic Issues
By John Morrow, Rathin DasProvides an in-depth examination of the status, upheavals, and challenges in the manufacturing arena of antibodies, in particular, and the biotherapeutics market place in general.
-
Biotechnology Entrepreneurship
By Holger Patzelt, Lars Schweizer, Judith BehrensThis article reviews the literature on biotechnology entrepreneurship. First, at the regional level, we focus on innovation networks and biotechnology clusters.
-
From Breakthrough to Blockbuster: The Business of Biotechnology
By Donald L. Drakeman, Lisa N. Drakeman, Nektarios Oraiopoulos4 (Winter 2007): 640–60. Siler, Kyle, Kirby Lee, and Lisa Bero. “Measuring the Effectiveness of Scientific Gatekeeping.” Proceedings of the National Academy of Sciences 112, no. 2 (January 2015): 360–65. Silva, Olmo.
-
2005 European Biotechnology VC Directory: European Venture Capital Companies and Contacts
2005 European Biotechnology VC Directory: European Venture Capital Companies and Contacts
-
Writing High-quality Standard Operating Procedures: A Practical Guide to Clear, Concise, and Correct Sops
By Atul MathurUnder the guidance of Atul Mathur, an engineer and a technical writer with over fifteen years of experience, you'll learn to identify the attributes of high-quality SOPs; create right content structure for SOPs; follow a systematic process ...
-
Bio1000, 1991-1992: World Biotechnology Company Directory
Bio1000, 1991-1992: World Biotechnology Company Directory
-
Career Opportunities in Clinical Drug Research
By Rebecca Jane AndersonThis book is an easy-to-follow handbook that introduces readers to entry-level clinical job opportunities and explains how to qualify for them, with a particular emphasis on how to gain clinical experience that a hiring manager will accept.